www.sciencedaily.com
A newly uncovered immune chain reaction explains the high colorectal cancer risk among inflammatory bowel disease (IBD) patients. Researchers found that a powerful inflammatory signal activates specialized gut immune cells, which then recruit and reprogram waves of white blood cells from the bone marrow. This immune remodeling creates a damaging, tumor-friendly environment that harms DNA in the gut lining and actively drives tumor growth.
Read More
